Lower socioeconomic status (SES) was not linked with hidradenitis suppurativa (HS) in minors, but was associated with obesity and tobacco use in this age group.
There is a significant association between a lower socioeconomic status (SES) and hidradenitis suppurativa (HS) in the adult population, results of a cross-sectional study show.
In addition, low SES is linked with obesity and tobacco consumption among children aged 7 to 17 years, although not with HS, according to an analysis of matched populations.
Findings were published in Journal of the European Academy of Dermatology and Venereology.
HS affects 1% to 2% of the world’s population, while previous research shows the condition has a negative impact on patients’ social, professional, and sexual lives. In addition, although a lower SES has been reported in patients with HS, limitations in available studies preclude researchers from drawing definitive conclusions, the investigators explained.
To address this knowledge gap, they assessed the SES of patients using a specific SES indicator, the French DEPrivation index (FDep). The FDep “is a multidimensional, area-based index that measures socioeconomic differences using 4 census-derived variables with 2 positive and 2 negative dimensions: the median income per household, the high school graduation rate in the population aged 15 years or older, the unemployment rate in the labor force, and the rate of blue-collar workers in the labor force,” the authors wrote.
They compared those hospitalized with HS with the general hospitalized population who did not have HS. Patients were aged 7 to 75 years and had at least 1 hospital stay between 2014 and 2021. All controls had at least 1 stay between 2016 and 2021 and had no diagnosis or history of diagnosis of HS.
A total of 33,880 patients with HS and 24,445,337 patients without HS were included in the analysis.
“After propensity score matching, logistic regression showed a significant association between HS and social disadvantage,” authors wrote.
Additional findings included the following:
On average, those in the HS group were younger and more likely to smoke and be obese.
Results suggest a relationship between poor social status, tobacco consumption, obesity, and HS, authors said, while several previous studies have pointed to the potential role of diet and tobacco in the development of the condition.
However, low SES is also a well-known risk factor for obesity and tobacco consumption, they added.
“In children, HS by itself is not linked to low SES, but it is associated with these 2 important risk factors. These results emphasize the critical need of fighting against smoking and obesity in children,” authors stressed.
In genetically predisposed individuals, early efforts made to combat these 2 risk factors could be beneficial to reduce the risk of HS.
Data also showed cardiovascular comorbidities, psychological disturbances, pilonidal sinus, spondyloarthropathies, and irritable bowel syndrome are all significantly higher among patients with HS compared with controls.
“With the demonstrated impact of HS on the quality of life, and the increased risk of comorbidities that we confirmed in the present study, it is crucial to promote early detection of HS and to provide the proper care to the patients, but also to detect and to treat the associated comorbidities,” the authors concluded.
Reference
Bulsei J, Fontas E, Passeron T. Hidradenitis suppurativa and social disadvantage: A nationwide administrative data study of the French hospitalized population. J Eur Acad Dermatol Venereol. Published online May 5, 2023. doi:10.1111/jdv.19159
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Patients With Actinic Keratosis Prefer Simulated Daylight PDT Over More Painful Red Light PDT
April 22nd 2024A recent study found that patients with actinic keratosis experienced more pain during red light photodynamic therapy (PDT) than simulated daylight PDT, emphasizing the need to understand patient experiences for better treatment decisions.
Read More
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More